Confounding factors influencing the effect of intravitreal triamcinolone for refractory diabetic macular edema

EVRS Educational Electronic Journal

Volumn 3, Issue 1, 2007, Pages 15-26

  Ahmadieh, Hamid ^a   Dehghan, M H ^a   Ramezani, A ^a   Yazdani, S ^a   Mohebbi, M R ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Confounding factors; Diabetic macular edema; Intravitreal triamcinolone; Macular thickness; Multivariate analysis

Indexed keywords

CHOLESTEROL; GLUCOSE; LIDOCAINE; NITROGEN; PLACEBO; TRIAMCINOLONE ACETONIDE; UREA;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA EXUDATE; RETINA FOVEA; RETINA MACULA CYSTOID EDEMA; UREA NITROGEN BLOOD LEVEL; VISUAL ACUITY;

EID: 34249946983     PISSN: 17653169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Jonas JB, Kreissig I, Söfker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57-61.
2. Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 2004; 88: 1131-1136.
3. Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 2004; 111: 2044-2049.
4. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004; 111: 218-224.
5. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE. Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 2002; 25: 2328-2334.
6. Roy MS, Klein R. Macular edema and retinal hard exudates in African Americans with type 1 diabetes: the New Jersey 725. Arch Ophthalmol 2001; 119: 251-259.
7. Arend O, Wolf S, Harris A, Reim M. The relationship of macular microcirculation to visual acuity in diabetic patients. Arch Ophthalmol 1995; 113: 610-614.
8. Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 1996; 114: 1079-1084.
9. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: early treatment diabetic retinopathy study report number 2. Ophthalmology 1987; 94: 761-774.
10. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002; 47( 2): 253-262.
11. Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991; 98: 1261-1265.
12. Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol 2004; 137: 675-682.
13. Jonas JB, Kreissig I, Degenring RF. Moshfeghi DM. The debate: steroid vs laser for retinal edema - the steroid advantage. Retina/Subspecialty Day 2003 abstracts; 81-83.
14. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001; 108: 765-772.
15. Conway MD, Canakis C, Livir-Rallatos C, Peyman GA. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 2003; 29: 27-33.
16. Arend O, Wolf S, Harris A, Reim M. The relationship of macular microcirculation to visual acuity in diabetic patients. Arch Ophthalmol 1995; 113: 610-614.
17. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995; 102: 7-16.